Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700298 | Clinical Oncology | 2006 | 7 Pages |
Abstract
Tumour stage remains the most important factor affecting outcome in radical radiotherapy of HNSCC. A definite dose-response relationship exists with higher total doses, leading to better local control, locoregional control and DFS in all stages. Site of primary affects outcome too, with laryngeal primaries doing well and oral cavity cancers faring the worst.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K.A. Dinshaw, J.P. Agarwal, S. Ghosh-Laskar, T. Gupta, S.K. Shrivastava,